| Title |
Author |
Type |
Date |
Words |
| Stem Cell Banking Market: Opportunities and Challenges. |
|
|
Oct 14, 2019 |
812 |
| Global Cell Therapy Technologies, Companies & Markets During the Forecast Period, 2018-2028. |
|
|
Oct 9, 2019 |
592 |
| Takeda Pharmaceutical announces results of Phase 2 TAK-620 study published. |
|
|
Sep 24, 2019 |
539 |
| Mustang Bio announces City of Hope opens Phase 1 trial of MB-105. |
|
|
Sep 23, 2019 |
272 |
| Gamida Cell and the CIBMTR Collaborate to Advance Research for Cellular Therapy. |
|
|
Sep 13, 2019 |
691 |
| Omeros announces FDA confirms schedule for rolling review of narsoplimab BLA. |
|
|
Sep 11, 2019 |
137 |
| Air, Rail And Road Transport Of Hematopoietic Stem Cell Transplants Linked To The Transplantation Activity Of The Hematology Department. |
|
|
Sep 11, 2019 |
332 |
| Gamida Cell, CIBMTR announce research agreement for HSTC patient data. |
|
Clinical report |
Sep 11, 2019 |
156 |
| Air, Rail And Road Transport Of Hematopoietic Stem Cell Grafts Linked To The Transplantation Activity Of The Hp-aph Hpu Hematology Unit. Sorbonne University Reference Number: Ap-hp.su 19-022. |
|
|
Sep 9, 2019 |
160 |
| Pathology of Gastrointestinal and Liver Complications of Hematopoietic Stem Cell Transplantation. |
Mourad, Nathalie; Michel, Rene P.; Marcus, Victoria A. |
|
Sep 1, 2019 |
9477 |
| Why Shares Of Micro-Cap Biotech Akari Therapeutics Are Ripping Higher. |
|
|
Aug 14, 2019 |
339 |
| Akari Therapeutics receives FDA Fast Track Designation for nomacopan. |
|
|
Aug 14, 2019 |
207 |
| Mustang Bio announces $9.28M grant to fund Phase 1 trial of MB-103. |
|
|
Aug 13, 2019 |
181 |
| City of Hope Scientist Receives USD 9.28m for CAR T Cell Immunotherapy Clinical Trial for Patients With HER2-Positive Breast Cancer That Has Spread to the Brain. |
|
|
Aug 13, 2019 |
663 |
| CASI Pharmaceuticals Announces Launch of EVOMELAA[R] (melphalan for injection) in China. |
|
|
Aug 12, 2019 |
1098 |
| Special edition of the SAMJ devoted to cell and gene therapy. |
Pepper, M.S. |
|
Aug 1, 2019 |
1218 |
| Primary immunodeficiency in Africa--a review. |
Erjaee, A.; Bagherpour, M.; van Rooyen, C.; van den Berg, S.; Kinnear, C.J.; PhD; Green, R.J.; Peppe |
|
Aug 1, 2019 |
8400 |
| Heterogeneity of cell therapy products. |
Wolmarans, E.; Mellet, J.; Ambele, M.A.; Durandt, C.; Pepper, M.S. |
|
Aug 1, 2019 |
4986 |
| Haematopoietic stem cell transplantation in South Africa: Current limitations and future perspectives. |
Grobbelaar, S.; Mercier, A.E.; Verburgh, E.; Brittain, D.; Pepper, M.S. |
|
Aug 1, 2019 |
6981 |
| Transplantation of gene-modified haematopoietic stem cells: Application and clinical considerations. |
Alessandrini, M.; Krause, K.-H.; Speck, R.F.; Pepper, M.S. |
|
Aug 1, 2019 |
5264 |
| Omeros and Lonza Enter Long-Term Manufacturing Agreement for Commercial Supply of Narsoplimab. |
|
|
Aug 1, 2019 |
547 |
| Global Cell Therapy Technologies, Markets and Companies Research to 2028 with Profiles of 300+ Companies. |
|
|
Jul 31, 2019 |
654 |
| Omeros, Lonza enter long-term manufacturing agreement for narsoplimab. |
|
|
Jul 31, 2019 |
106 |
| Iran to Open Center for Hematopoietic Stem Cell Transplantation in Iraq. |
|
|
Jul 28, 2019 |
336 |
| Light Therapy May Prevent Oral Mucositis for Some in Cancer Tx; Laser, other light tx recommended for patients treated with HSCT; head and neck RT with, without chemo. |
|
|
Jul 22, 2019 |
235 |
| Omeros announces agreement with FDA on primary endpoint for narsoplimab trial. |
|
|
Jul 11, 2019 |
287 |
| Family seeks support for young man's treatment. |
|
|
Jul 10, 2019 |
214 |
| Two-Dose Course of Vaccine After HSCT Cuts Incidence of Zoster; Incidence of herpes zoster decreased during median 21-month follow-up after autologous HSCT. |
|
|
Jul 10, 2019 |
264 |
| Gamida Cell and Lonza to IManufacture Omidubicel. |
|
|
Jul 1, 2019 |
322 |
| Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents. |
Gavriilaki, Maria; Sakellari, Ioanna; Gavriilaki, Eleni; Kimiskidis, Vasilios K.; Anagnostopoulos, A |
|
Jul 1, 2019 |
7016 |
| United States : Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel. |
|
|
Jun 26, 2019 |
188 |
| Gamida Cell partners with Lonza for the manufacturing and launch of Omidubicel. |
|
|
Jun 19, 2019 |
236 |
| Gamida Cell partners with Lonza for the manufacturing and launch of Omidubicel. |
|
|
Jun 19, 2019 |
232 |
| Gamida Cell, Lonza enter strategic manufacturing agreement. |
|
|
Jun 19, 2019 |
163 |
| Viralym-M Granted Regenerative Medicine Advanced Therapy Designation for the Treatment of Hemorrhagic Cystitis Caused by BK Virus in Adults and Children Following Allogeneic HSCT. |
|
|
Jun 13, 2019 |
691 |
| Rapporteurs Assigned for European Marketing Authorisation Application for Narsoplimab for Treatment of HSCT-TMA. |
|
|
Jun 7, 2019 |
676 |
| The European Commission grants conditional marketing authorisation to bluebird bio's ZYNTEGLO. |
|
|
Jun 5, 2019 |
212 |
| The European Commission grants conditional marketing authorisation to bluebird bio's ZYNTEGLO. |
|
|
Jun 5, 2019 |
208 |
| Bluebird Bio announces EU conditional marketing authorization for ZYNTEGLO. |
|
|
Jun 3, 2019 |
197 |
| Air, Rail And Road Transport Of Hematopoietic Stem Cell Grafts Related To The Transplantation Activity Of The Clinical Hematology Unit Of The Aphp Hospital Group. |
|
|
May 29, 2019 |
298 |
| First Subjects Dosed In Phase 1 Trial Of Stem Cell Mobilization Factor. |
|
|
May 6, 2019 |
426 |
| Autologous Peripheral Blood Stem Cell Transplantation Among Lymphoproliferative Disease Patients: Factors Influencing Engraftment. |
|
Correction notice |
May 1, 2019 |
177 |
| First Subjects Dosed In Phase 1 Trial Of Stem Cell Mobilization Factor. |
|
|
Apr 29, 2019 |
426 |
| First Subjects Dosed In Phase 1 Trial Of Stem Cell Mobilization Factor. |
|
|
Apr 29, 2019 |
426 |
| First Subjects Dosed in Phase 1 Clinical Trial of MGTA-145, a First-Line Stem Cell Mobilization Product Candidate. |
|
|
Apr 25, 2019 |
196 |
| 'If I met the girl who saved my life, I'd give her the biggest hug'. |
|
|
Apr 20, 2019 |
697 |
| British patient cured of HIV; MEDICAL MARVELS. |
|
|
Apr 19, 2019 |
173 |
| British patient cured of HIV [...]. |
|
|
Apr 19, 2019 |
173 |
| Omeros announces EBMT case report of resolution of gastrointestinal HSCT-TMA. |
|
|
Apr 3, 2019 |
283 |
| Pacific Biosciences announces retrospective study on PacBio sequencing published. |
|
|
Apr 2, 2019 |
318 |
| bluebird bio Receives Positive Opinion from CHMP for Zynteglo Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent I[superscript two]-Thalassemia Who Do Not Have I[superscript two]0/I[superscript two]0 Genotype. |
|
|
Apr 2, 2019 |
815 |
| Study identifies post-HCT risk factors for skin cancer. |
Rans, Caleb |
|
Apr 1, 2019 |
395 |
| Bluebird Bio receives positive opinion from CHMP for ZYNTEGLO. |
|
|
Mar 29, 2019 |
160 |
| Breath Therapeutics begins global Phase 3 trials of La[euro]'CsAa[euro]'i for treating Bronchiolitis Obliterans Syndrome. |
|
|
Mar 26, 2019 |
252 |
| Breath Therapeutics begins global Phase 3 trials of La[euro]'CsAa[euro]'i for treating Bronchiolitis Obliterans Syndrome. |
|
|
Mar 26, 2019 |
248 |
| FDA Approves Trial Of Treatment In Stem Cell Transplant-Related Condition. |
|
|
Mar 25, 2019 |
346 |
| DSMB Approves Enrollment of Final Conort In Phase 1 Hematological Study. |
|
|
Mar 25, 2019 |
382 |
| FDA Approves Trial Of Treatment In Stem Cell Transplant-Related Condition. |
|
|
Mar 18, 2019 |
346 |
| DSMB Approves Enrollment of Final Cohort In Phase 1 Hematological Study: First Two Cohorts Show Primary Safety Endpoint Met, Plus Early Signs Of Efficacy. |
|
|
Mar 18, 2019 |
369 |
| FDA Approves Trial Of Treatment In Stem Cell Transplant-Related Condition. |
|
|
Mar 18, 2019 |
346 |
| DSMB Approves Enrollment of Final Cohort In Phase 1 Hematological Study. |
|
|
Mar 18, 2019 |
382 |
| Pluristem completes enrollment in second cohort of PLX-R18 trial. |
|
|
Mar 12, 2019 |
109 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
460 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
457 |
| HIV hope as man cleared of killer virus. |
|
|
Mar 6, 2019 |
166 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
457 |
| Transplant 'cures' man of HIV virus. |
|
|
Mar 6, 2019 |
113 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| Man 'cured' of HIV after stem cell transplant. |
|
|
Mar 6, 2019 |
202 |
| Brit is 'cured' of HIV. |
|
|
Mar 6, 2019 |
351 |
| Man is 'cured' of HIV; Virus-free after stem cell swap. |
|
|
Mar 6, 2019 |
360 |
| Tests on London patient offer hope of HIV 'cure'. |
|
|
Mar 5, 2019 |
789 |
| Data Presented On Stem Cell Mobilization Product For Bone Marrow Transplant. |
|
|
Mar 4, 2019 |
258 |
| Data Presented On Stem Cell Mobilization Product For Bone Marrow Transplant. |
|
|
Mar 4, 2019 |
258 |
| Chimerix presents results from Phase 3 SUPPRESS trial. |
|
|
Feb 22, 2019 |
247 |
| Vical to discontinue development of VL-2397, to consider strategic options. |
|
|
Feb 19, 2019 |
133 |
| Omeros Streamlines Path to Biologics License Application for OMS721 in HSCT-TMA Following Meeting with FDA. |
|
|
Feb 19, 2019 |
987 |
| Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells. |
|
|
Feb 2, 2019 |
335 |
| Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation. |
Atilla, Erden; Atilla, Pinar Ataca; Seval, Guldane Cengiz; Bektas, Mehmet; Demirer, Taner |
Report |
Feb 1, 2019 |
7231 |
| CMV-specific immune system monitoring for management of cytomegalovirus in HSCT. |
Blanchard, Ted; Cruikshank, William |
|
Jan 1, 2019 |
2891 |
| Fecal Microbiota Transplantation. |
|
|
Jan 1, 2019 |
430 |
| Preconditioning with SDF-1 Improves Therapeutic Outcomes of Bone marrow-derived Mesenchymal Stromal Cells in a Mouse Model of STZ-induced Diabetes. |
Farashah, Mohammad Sadegh Gholami; Pasbakhsh, Parichehr; Omidi, Ameneh; Nekoonam, Saied; Aryanpour, |
Report |
Jan 1, 2019 |
4357 |
| Clinical and Radiologic Characteristics of Human Metapneumovirus Infections in Adults, South Korea. |
Koo, Hyun Jung; Lee, Han Na; Choi, Sang Ho; Sung, Heungsup; Kim, Hwa Jung; Do, Kyung-Hyun |
|
Jan 1, 2019 |
8161 |
| Autologous Peripheral Blood Stem Cell Transplantation Among Lymphoproliferative Disease Patients: Factors Influencing Engraftment. |
Hassan, Mohd Nazri; Fauzi, Hafizuddin Mohamed; Husin, Azlan; Mustaffa, Rapiaah; Hassan, Rosline; Ibr |
Report |
Jan 1, 2019 |
6597 |
| BETA-TALASEMIA: UN MUNDO DE COMPLICACIONES CON NUEVAS ALTERNATIVAS DE TRATAMIENTO. |
Carvajal Alzate, Manuela |
|
Jan 1, 2019 |
6307 |
| Omeros Seeks European Medicines Nod for Clinical Strategy to Accelerate Pediatric Development of OMS721 for the Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy. |
|
|
Dec 10, 2018 |
1072 |
| Magenta Therapeutics Presents New Data from Phase 2 Study of MGTA-456 Cell Therapy in Patients with Inherited Metabolic Disorders. |
|
|
Dec 6, 2018 |
527 |
| Omeros submits pediatric investigational plan for use of OMS721 to EMA. |
|
|
Dec 6, 2018 |
439 |
| Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. |
Liu, Jing; Zhao, Xiao-Su; Liu, Yan-Rong; Xu, Lan-Ping; Zhang, Xiao-Hui; Chen, Huan; Chen, Yu-Hong; W |
Report |
Dec 5, 2018 |
5367 |
| CASI Pharmaceuticals wins approval of Melphalan Hydrochloride for Injection in China. |
|
|
Dec 4, 2018 |
250 |
| Gamida Cell publishes data from Phase 1/2 clinical study of NiCord. |
|
Clinical report |
Dec 4, 2018 |
135 |
| CASI Pharmaceuticals gets Chinese OK for multiple myeloma drug. |
|
|
Dec 3, 2018 |
268 |
| Pluristem presents Phase 1 PLX-R18 trial data at ASH. |
|
|
Dec 3, 2018 |
260 |
| Gamida Cell says NiCord recipients demonstrated immune reconstitution in study. |
|
|
Dec 3, 2018 |
393 |
| Magenta presents new data on MGTA-145 stem cell mobilization product candidate. |
|
|
Dec 2, 2018 |
185 |
| Pluristem to present first cohort from PLX-418 study at ASH meeting. |
|
|
Nov 28, 2018 |
200 |
| Orphan Drug Designation For Treatment Of Stem Cell Transplant-Related Disorder. |
|
|
Oct 29, 2018 |
365 |
| Orphan Drug Designation For Treatment Of Stem Cell Transplant-Related Disorder. |
|
|
Oct 29, 2018 |
365 |
| Chimerix presents preclinical data showing antiviral activity of Brincidofovir. |
|
|
Oct 28, 2018 |
163 |
| Omeros granted FDA Orphan Drug Designation for OMS721. |
|
|
Oct 23, 2018 |
164 |
| Bioinformatics Tool Can ID Source of Bloodstream Pathogens; Classically non-enteric pathogens identified in gut microbiome, challenging origin of these infections. |
|
|
Oct 19, 2018 |
194 |
| First Patient Dosed in Phase 2 Clinical Trial of MaaT Pharma Lead Product MaaT013, a First-in-class Biotherapeutic to Treat Acute GvHD. |
|
|
Oct 12, 2018 |
450 |
| Chimerix study shows correlation of Adv burden, allo-HCT recipients mortality. |
|
|
Oct 4, 2018 |
107 |
| Can Therapeutically-Rational Exchange (T-REX) of Thalassemic Red Blood Cells Improve the Clinical Course of Plasmodium falciparum Malaria? |
Jajosky, Ryan Philip; Jajosky, Audrey N.; Jajosky, Philip G. |
|
Oct 1, 2018 |
822 |
| CytoSen Therapeutics Receives FDA's Favorable Response to Pre-IND Meeting Package for Phase 2 Study in AML. |
|
|
Sep 28, 2018 |
455 |
| United States : Fecal microbiota transplantation helps restore beneficial bacteria in cancer patients. |
|
|
Sep 28, 2018 |
445 |
| Pluristem PLX cell therapy granted FDA Orphan Drug Designation. |
|
|
Sep 25, 2018 |
136 |
| Be The Match[R] and Illusionist Jim Munroe Launch #MakeCancerDisappear Public Challenge Today. |
|
|
Sep 20, 2018 |
661 |
| Nine things you should know about blood stem cell donation; As new research finds that two-thirds of Brits wouldn't donate their stem cells, LISA SALMON asks experts to dispel some of the most common myths. |
|
|
Sep 19, 2018 |
979 |
| Cambodian Thalassemia kids given new lives after Indian help. |
|
|
Sep 17, 2018 |
920 |
| Bluebird Bio presents updated data on Phase 2 Starbeam study of Lenti-D. |
|
|
Sep 5, 2018 |
368 |
| Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation. |
Huang, Wen-Rong; Liu, Dai-Hong |
Report |
Sep 5, 2018 |
6001 |
| The case for full-length sequencing for high-resolution HLA typing. |
Cereb, Nezih |
|
Sep 1, 2018 |
973 |
| Use of the National Institutes of Health Consensus Guidelines Improves the Diagnostic Sensitivity of Gastrointestinal Graft-Versus-Host Disease. |
Cardona, Diana M.; Detweiler, Claire J.; Shealy, Michael J.; Sung, Anthony D.; Wild, Daniel M.; Pole |
Report |
Sep 1, 2018 |
6970 |
| United States : European Commission Approves BLINCYTO (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. |
|
|
Aug 30, 2018 |
281 |
| European Commission Approves Blincyto for Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic. |
|
|
Aug 30, 2018 |
747 |
| European Commission Designates OMS721 as an Orphan Medicinal Product for Treatment in Hematopoietic Stem Cell Transplantation. |
|
|
Aug 29, 2018 |
730 |
| Omeros: OMS721 designated Orphan Medicinal Product in EU for HSCT. |
|
|
Aug 28, 2018 |
104 |
| Development Of Advanced Technologies For Gene Therapy Manufacture. |
|
|
Aug 25, 2018 |
365 |
| SISTER'S SACRIFICE; Three-year-old could be donor for Michael. |
|
|
Aug 18, 2018 |
391 |
| Nine things you should know about blood stem cell donation; As new research finds that two-thirds of Brits wouldn't donate their stem cells, LISA SALMON asks experts to dispel some of the most common myths. |
|
|
Aug 16, 2018 |
1010 |
| Nine things you should know about blood stem cell donation; As new research finds that two-thirds of Brits wouldn't donate their stem cells, LISA SALMON asks experts to dispel some of the most common myths. |
|
|
Aug 14, 2018 |
1019 |
| Nine things you should know about blood stem cell donation; As new research finds that two-thirds of Brits wouldn't donate their stem cells, LISA SALMON asks experts to dispel some of the most common myths. |
|
|
Aug 14, 2018 |
1017 |
| Nine things you should know about blood stem cell donation; As new research finds that two-thirds of Brits wouldn't donate their stem cells, LISA SALMON asks experts to dispel some of the most common myths. |
|
|
Aug 14, 2018 |
1017 |
| Nine things you should know about blood stem cell donation; As new research finds that two-thirds of Brits wouldn't donate their stem cells, LISA SALMON asks experts to dispel some of the most common myths. |
|
|
Aug 14, 2018 |
1062 |
| Nine things you should know about blood stem cell donation. |
|
|
Aug 14, 2018 |
1030 |
| Nine things you should know about blood stem cell donation; As new research finds that two-thirds of Brits wouldn't donate their stem cells, LISA SALMON asks experts to dispel some of the most common myths. |
|
|
Aug 14, 2018 |
971 |
| Nine things you should know about blood stem cell donation. |
|
|
Aug 14, 2018 |
1045 |
| Nine things you should know about blood stem cell donation; As new research finds that two-thirds of Brits wouldn't donate their stem cells, LISA SALMON asks experts to dispel some of the most common myths. |
|
|
Aug 13, 2018 |
968 |
| Nine things you should know about blood stem cell donation; As new research finds that two-thirds of Brits wouldn't donate their stem cells, LISA SALMON asks experts to dispel some of the most common myths. |
|
|
Aug 13, 2018 |
1028 |
| BioLineRx says 'extremely encouraged' by lead-in period of Phase 3 GENESIS trial. |
|
|
Aug 7, 2018 |
296 |
| Photodamage predicts skin cancer risk after transplant. |
Jancin, Bruce |
|
Aug 1, 2018 |
719 |
| Toxoplasmosis in Transplant Recipients, Europe, 2010-2014. |
Robert-Gangneux, Florence; Meroni, Valeria; Dupont, Damien; Botterel, Frangoise; Garcia, Jose M. Agu |
|
Aug 1, 2018 |
6789 |
| Investigation of BK Virus Infections in Haematopoietic Stem Cell Transplant Recipients/ BK Virusu Infeksiyonlarinin Hematopoetik Kok Hucre Transplanti Alicilarinda Arastirilmasi. |
Kaya, Nazli Nida; Bayram, Ibrahim; Seflek, Buket; Kupeli, Serhan; Ozdogru-Sagdic, Deniz; Sezgin, Gul |
Report |
Aug 1, 2018 |
2787 |
| The European Medicines Agency's committee adopts positive opinion on Omeros' OMS721 orphan drug designation. |
|
|
Jul 27, 2018 |
230 |
| The European Medicines Agency's committee adopts positive opinion on Omeros' OMS721 orphan drug designation. |
|
|
Jul 27, 2018 |
226 |
| Omeros says OMS721 receives European Orphan Drug designation positive opinion. |
|
|
Jul 25, 2018 |
254 |
| Atara reports positive Phase 2 results for tab-cel. |
|
Financial report |
Jun 15, 2018 |
316 |
| Atara reports positive Phase 2 results for tab-cel. |
|
Financial report |
Jun 15, 2018 |
312 |
| Atara Biotherapeutics Tab-cel achieves long-term outcomes in Phase 2 studies. |
|
|
Jun 15, 2018 |
194 |
| Pakistan citizen to have received cord blood discharged from hospital in China. |
|
|
Jun 2, 2018 |
447 |
| Galactomannan Antigen Detection as a Screening Tool For Early Diagnosis of Invasive Aspergillosis: Experience of Turkish Adult Patients. |
Metan, Gokhan; Akan, Hamdi |
Report |
Jun 1, 2018 |
3421 |
| Ultrasensitive Detection of Chimerism by Single-Molecule Molecular Inversion Probe Capture and High-Throughput Sequencing of Copy Number Deletion Polymorphisms. |
Wu, David; Waalkes, Adam; Penewit, Kelsi; Salipante, Stephen J. |
|
Jun 1, 2018 |
6843 |
| BioLineRx reports Phase 2 results on BL-8040 for stem cell mobilization. |
|
Financial report |
May 17, 2018 |
196 |
| Japan : Daiichi Sankyo Announces Single Agent Quizartinib Significantly Prolongs Overall Survival Compared with Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations (QuANTUM-R Study). |
|
Clinical report |
May 12, 2018 |
298 |
| Omeros Garners FDA Breakthrough Therapy Designation for MASP-2 Inhibitor for Treatment of Thrombotic Microangiopathy Associated with Hematopoietic Stem Cell Transplant. |
|
|
May 1, 2018 |
239 |
| The US Food and Drug Administration grants breakthrough therapy designation to Omeros' OMS721. |
|
|
Apr 30, 2018 |
170 |
| The US Food and Drug Administration grants breakthrough therapy designation to Omeros' OMS721. |
|
|
Apr 30, 2018 |
166 |
| Pakistani receives transplantation of cord blood hematopoietic stem cells in China. |
|
|
Apr 27, 2018 |
141 |
| Pakistani's stem cell transplanted in Shanghai. |
|
|
Apr 27, 2018 |
123 |
| Gene-Edited Stem Cells Show Promise Against HIV In Monkey Tests. |
|
|
Apr 23, 2018 |
441 |
| Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia. |
Dou, Li-Ping; Li, Hong-Hua; Wang, Lu; Li, Fei; Huang, Wen-Rong; Yu, Li; Liu, Dai-Hong |
Report |
Apr 15, 2018 |
5571 |
| Fate reports no events of cancer relapse in Phase 1 stage of PROTECT trial. |
|
|
Mar 19, 2018 |
370 |
| Kiadis Pharma raises EUR23.4m in private placement. |
|
|
Mar 15, 2018 |
156 |
| Kiadis Pharma raises EUR23.4m in private placement. |
|
|
Mar 15, 2018 |
152 |
| Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation. |
Seval, Guldane Cengiz; Toptjuoglu, Pervin; Demirer, Taner |
Report |
Mar 1, 2018 |
8567 |
| Pluristem says PLX-R18 improves hematopoietic transplantation. |
|
|
Feb 27, 2018 |
221 |
| Kadmon reveals updated positive results from Phase 2 study of KD025 in cGVHD. |
|
|
Feb 23, 2018 |
303 |
| Kadmon reveals updated positive results from Phase 2 study of KD025 in cGVHD. |
|
|
Feb 23, 2018 |
299 |
| Vical initiates Phase 2 Trial of VL-2397 antifungal for invasive aspergillosis. |
|
|
Feb 20, 2018 |
128 |
| Omeros says four deaths occur during Phase 2 study of OMS721. |
|
|
Feb 15, 2018 |
419 |
| Stem-cell transplantation for scleroderma beats cyclophosphamide. |
Laubach, Lori |
|
Feb 1, 2018 |
345 |
| Astellas and Vical reveal topline results from Phase 3 trial for ASP0113 vaccine. |
|
Clinical report |
Jan 22, 2018 |
187 |
| Astellas and Vical reveal topline results from Phase 3 trial for ASP0113 vaccine. |
|
Clinical report |
Jan 22, 2018 |
183 |
| Omeros receives positive opinion for OMS721 from EMA. |
|
|
Jan 22, 2018 |
221 |
| United States : Stem cell transplant for severe scleroderma improves survival, quality of life. |
|
|
Jan 5, 2018 |
802 |
| HSCT-GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature. |
Grant, Michael J.; Horwitz, Mitchell E. |
|
Jan 1, 2018 |
3555 |
| Human Mesenchymal Stem/Stromal Cells from Umbilical Cord Blood and Placenta Exhibit Similar Capacities to Promote Expansion of Hematopoietic Progenitor Cells In Vitro. |
Fajardo-Orduna, Guadalupe R.; Mayani, Hector; Flores-Guzman, Patricia; Flores-Figueroa, Eugenia; Her |
|
Jan 1, 2018 |
6029 |
| Therapeutic Use of Extraembryonic-Derived Tissues. |
Uhlin, Michael; Abumaree, Mohamed; Abdelalim, Essam M. |
|
Jan 1, 2018 |
855 |
| Recovery of Donor Hematopoiesis after Graft Failure and Second Hematopoietic Stem Cell Transplantation with Intraosseous Administration of Mesenchymal Stromal Cells. |
Petinati, Nataliya; Drize, Nina; Sats, Natalia; Risinskaya, Natalya; Sudarikov, Andrey; Drokov, Mich |
|
Jan 1, 2018 |
5344 |
| Public Awareness on Cord Blood Banking in Saudi Arabia. |
Jawdat, Dunia; AlTwijri, Sulaiman; AlSemari, Hadeel; Saade, Mayssa; Alaskar, Ahmed |
|
Jan 1, 2018 |
2914 |
| EBV Infection in XLP1 Manifested Solely by Behavioral Aggression and Effective Treatment Using Rituximab. |
Korah-Sedgwick, Michelle M.; Wall, Luke A. |
|
Jan 1, 2018 |
2073 |
| An X-Linked Hyper-IgM Patient Followed Successfully for 23 Years without Hematopoietic Stem Cell Transplantation. |
Kutukculer, Necil; Karaca, Neslihan Edeer; Aksu, Guzide; Aykut, Ayca; Pariltay, Erhan; Cogulu, Ozgur |
|
Jan 1, 2018 |
2815 |
| Toxoplasma Encephalitis following Tandem Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Review of the Literature. |
Kollu, Vidya; Magalhaes-Silverman, Margarida; Tricot, Guido; Ince, Dilek |
|
Jan 1, 2018 |
2147 |
| Neutralizing Potential of Fab IgG Hybrid Antibody Against Dengue Virus (DENV-1,2,3,4) Expressed on Mesenchymal Stem Cells/Mezenkimal Kok Hucreler Uzerinde Dengue Virusune Karsi (DENV-1,2,3,4) Fab IgG Hibrit Antikorunun Notralize Edici Potansiyeli. |
Rantam, Fedik A.; Ernawati, Rahaju; Rahmahani, Jola; Hendrianto, Eryk; Susilowati, Helen; A'La, Rofq |
|
Jan 1, 2018 |
4307 |
| Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence. |
Kuba, Adam; Raida, Ludek |
|
Jan 1, 2018 |
9456 |
| High-Risk Leukemia: Past, Present, and Future Role of NK Cells. |
Mavers, Melissa; Bertaina, Alice |
|
Jan 1, 2018 |
10462 |
| The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation. |
Karabon, Lidia; Markiewicz, Miroslaw; Chrobot, Karolina; Dzierzak-Mietla, Monika; Pawlak-Adamska, Ed |
|
Jan 1, 2018 |
5392 |
| Role of Regulatory T Cells in Tumor-Bearing Mice Treated with Allo-Hematopoietic Stem Cell Transplantation Plus Thymus Transplantation. |
Hosaka, Naoki |
|
Jan 1, 2018 |
5029 |
| Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for Children and Young Adults with Relapsed Ewing's Sarcoma: A Systematic Review. |
Tenneti, Pavan; Zahid, Umar; Iftikhar, Ahmad; Yun, Seongseok; Sohail, Atif; Warraich, Zabih; Anwer, |
Report |
Jan 1, 2018 |
8653 |
| Establishing Hematopoietic Stem Cell Transplant Unit in Resource Limited Setting: A Critical Analysis of Indian Council of Medical Research 2017 Guidelines. |
Das, Kunal; Khanna, Tanvi; Agrawal, Nitika |
|
Jan 1, 2018 |
3043 |
| Switzerland : Phase II data showed Roches investigational polatuzumab vedotin plus bendamustine and MabThera/Rituxan (BR) increased complete response rates compared to BR alone in previously treated aggressive lymphoma. |
|
|
Dec 11, 2017 |
411 |
| Merck Publishes Phase 3 Clinical Study of Prevymis (letermovir) CMV Prophylaxis Medicine. |
|
Clinical report |
Dec 7, 2017 |
168 |
| GSK reveals positive Phase III trial data for Shingrix. |
|
|
Dec 6, 2017 |
248 |
| GSK reveals positive Phase III trial data for Shingrix. |
|
|
Dec 6, 2017 |
244 |
| Alopecia may be permanent in one in four pediatric HSCT patients. |
Oakes, Kari |
Clinical report |
Dec 1, 2017 |
302 |
| DEVELOPMENT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION AT THE CLINIC OF HEMATOLOGY, CLINICAL CENTER OF VOJVODINA IN NOVI SAD/RAZVOJ TRANSPLANTACIJE MATICNIH CELIJA HEMATOPOEZE NA KLINICI ZA HEMATOLOGIJU KLINICKOG CENTRA VOJVODINE U NOVOM SADU. |
Pejin, Dusan |
Report |
Dec 1, 2017 |
3514 |
| ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AT THE CLINICAL CENTER OF VOJVODINA/ALOGENA TRANSPLANTACIJA MATICNIH CELIJA HEMATOPOEZE U KLINICKOM CENTRU VOJVODINE. |
Farra, Amir El; Sekulic, Borivoj; Urosevic, Ivana; Popovic, Stevan; Pejin, Dusan; Savic, Aleksandar |
Report |
Dec 1, 2017 |
2821 |
| AUTOLOGOUS STEM CELL TRANSPLANTATION FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES IN THE CLINICAL CENTER OF VOJVODINA/AUTOLOGNA TRANSPLANTACIJA MATICNIH CELIJA HEMATOPOEZE ULECENJU HEMATOLOSKIHMALIGNITETA U KLINICKOM CENTRU VOJVODINE. |
Urosevic, Ivana; Savic, Ivanka; Farra, Amir EL; Sekulic, Borivoj; Savic, Aleksandar; Balint, Bela |
Report |
Dec 1, 2017 |
3857 |
| OPTIMIZATION OF TIMING FOR HEMATOPOIETIC STEM CELL TRANSPLANTATIONS IN PATIENTS WITH MYELOID LEUKEMIA/OPTIMIZACIJA VREMENA ZA TRANSPLANTACIJU HEMATOPOEZNIHMATICNIH CELIJA KOD PACIJENATA SA MIJELOIDNIM LEUKEMIJAMA. |
Popovic, Stevan L. |
Report |
Dec 1, 2017 |
6594 |
| STEM CELL TRANSPLANT: FROM CELL HARVESTING TO CRYOPRE SERVATION/TRANSPLANTACIJA MATICNIH CELIJA: OD PRIKUPLJANJA DO KRIOKONZERVACIJE. |
Balint, Bela; Todorovic, Milena; Urosevic, Ivana; Pavlovic, Mirjana |
Report |
Dec 1, 2017 |
3415 |
| AUTOLOGOUS STEM CELL TRANSPLANTS--SINGLE CENTER STANDPOINTS FOR LYMPHOMA PATIENTS/AUTOLOGNA TRANSPLANTACIJA MATICNIH CELIJA HEMATOPOEZE--STAVOVI JEDNOG CENTRA ZA PACIJENTE SA LIMFOMIMA. |
Todorovic Balint, Milena; Balint, Bela; Bila, Jelena; Vujic, Dragana; Andelic, Bosko; Mihaljevic, Bi |
Report |
Dec 1, 2017 |
2231 |
| THE ROLE OF HIGH-DOSE THERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA/ULOGA VISOKODOZNE TERAPIJE I AUTOLOGNE TRANSPLANTACIJE MATICNIH CELIJA U LECENJU PACIJENATA SA MULTIPLIM MIJELOMOM. |
Bila, Jelena; Jelicic, Jelena; Todorovic Balint, Milena; Antic, Darko; Vujic, Dragana; Mihaljevic, B |
Report |
Dec 1, 2017 |
1871 |
| MATCHED UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION--OUR RESULTS/TRANSPLANTACIJA MATICNIH CELIJA HEMATOPOEZE OD NESRODNOG DAVAOCA - NASI REZULTATI. |
Elez, Marija; Atanaskovic, Lavinika; Mirosavljevic, Svetlana; Ostojic, Gordana; Todoric Zivanovic, B |
Report |
Dec 1, 2017 |
1416 |
| A Bibliometric Study: 45 Years of Biomedical Literature in Hematopoietic Stem Cell Transplantation/Estudio bibliometrico: 45 anos de literatura biomedica en trasplante de celulas madre hematopoyeticas/Estudo bibliometrico: 45 anos de literatura biomedica em transplante de celulas-tronco hematopoieticas. |
Rios-Moreno, Jenifer Vanessa; Bueno-Florez, Silvia Juliana; Conde-Hurtado, Diana Isabel; Tarazona, N |
Report |
Dec 1, 2017 |
3441 |
| 5,000 miles to ease my pain; North East mum deemed'too disabled'to receive NHS care. |
|
|
Nov 18, 2017 |
547 |
| Mum crippled by MS flies to India for treatment; susan 'too disabled' to to receive therapy on nhs - claim. |
|
|
Nov 18, 2017 |
513 |
| US Food and Drug Administration approves Merck's Prevymis. |
|
|
Nov 13, 2017 |
229 |
| US Food and Drug Administration approves Merck's Prevymis. |
|
|
Nov 13, 2017 |
225 |
| US FDA Approves US Merck's Prevymis for Prevention of Cytomegalovirus Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients. |
|
|
Nov 10, 2017 |
187 |
| United States : Merck Receives FDA Approval of PREVYMIS (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients. |
|
|
Nov 9, 2017 |
170 |
| Transplanted Hematopoietic Stem Cells Reverse Damage From Friedreich's Ataxia. |
|
|
Nov 6, 2017 |
403 |
| Stem Cells Subset Is Source Of All Cells In Blood, Immune Systems. |
|
|
Nov 6, 2017 |
718 |
| A Complete Histologic Approach to Gastrointestinal Biopsy From Hematopoietic Stem Cell Transplant Patients With Evidence of Transplant-Associated Gastrointestinal Thrombotic Microangiopathy. |
Warren, Mikako; Jodele, Sonata; Dandoy, Christopher; Myers, Kasiani C.; Wallace, Gregory; Nelson, Ad |
Report |
Nov 1, 2017 |
5824 |
| Phase III. |
|
|
Nov 1, 2017 |
246 |
| HMC conducts Qatar's first allogeneic stem cell transplantation on blood cancer patient. |
|
|
Oct 30, 2017 |
574 |
| HMC conducts Qatar's first allogeneic stem cell transplant. |
|
|
Oct 30, 2017 |
101 |
| Qatar's First Allogeneic Stem Cell Transplantation Takes Place at HMC. |
|
|
Oct 29, 2017 |
578 |
| Omeros Reports Additional Positive Data from Phase 2 Study of OMS721 in Patients with HCT-TMA. |
|
|
Oct 27, 2017 |
343 |
| Treatment of Patient with Omeros' OMS721 Results in Resolution of Both HCT-TMA and GvHD. |
|
|
Oct 23, 2017 |
311 |
| Enterovirus D68-Associated Acute Flaccid Myelitis in Immunocompromised Woman, Italy. |
Giombini, Emanuela; Rueca, Martina; Barberi, Walter; Iori, Anna Paola; Inghilleri, Maurizio; Castill |
Clinical report |
Oct 1, 2017 |
2267 |
| Acute Graft-Versus-Host Disease Prognosis: Are Biomarkers Ready for Preemptive Clinical Trials? |
Paczesny, Sophie |
Essay |
Oct 1, 2017 |
2066 |
| Better SC transplantation method could reduce side effects. |
|
|
Sep 18, 2017 |
520 |
| Better SC transplantation method could reduce side effects. |
|
|
Sep 18, 2017 |
520 |
| Improved SC transplantation technique could reduce adverse side effects. |
|
|
Sep 11, 2017 |
520 |
| Non-malignant late effects in lymphoma patients treated with autologous hematopoietic stem cell transplantation/Otolog hematopoietik kok hucre nakli yapilan lenfomali hastalarda malign olmayan gec etkiler. |
Sirmatel, Pinar; Yilmaz, Hulya; Gunduz, Eren |
Report |
Sep 1, 2017 |
3583 |
| Frequency of Mycobacterium bovis and mycobacteria in primary immunodeficiencies. |
Ulusoy, Ezgi; Karaca, Neslihan Edeer; Aksu, Guzide; Cavusoglu, Cengiz; Kutukculer, Necil |
Report |
Sep 1, 2017 |
3627 |
| BioLineRx files for Phase 3 registrational study of BL-8040 for stem cell mobilisation in patients with multiple myeloma. |
|
|
Aug 22, 2017 |
290 |
| BioLineRx files for Phase 3 registrational study of BL-8040 for stem cell mobilisation in patients with multiple myeloma. |
|
|
Aug 22, 2017 |
294 |
| Impact of Human Leukocyte Antigen Loci and Haplotypes on Intestinal Acute Graft-versus-host Disease after Human Leukocyte Antigen-matched Sibling Peripheral Blood Stem Cell Transplantation. |
Yan, Fa-Hong; Wang, Mei; Yao, Jian-Feng; Jiang, Er-Lie; Han, Ming-Zhe |
Report |
Jul 27, 2017 |
4451 |
| Disseminated Mycobacterium genavense infection in patient with adult-onset immunodeficiency. |
Asakura, Takanori; Namkoong, Ho; Sakagami, Takuro; Hasegawa, Naoki; Ohkusu, Kiyofumi; Nakamura, Akir |
|
Jul 1, 2017 |
1370 |
| Hepatosplenic mucormycosis post autologous stem cell transplant. |
|
|
Jun 30, 2017 |
1544 |
| Spain : Bellicum Reports Clinical Results of BPX-501 in Pediatric Leukemias at the 22nd Congress of the European Hematology Association. |
|
Clinical report |
Jun 24, 2017 |
455 |
| Enterocytozoon bieneusi microsporidiosis in stem cell transplant recipients treated with fumagillin. |
Bukreyeva, Iryna; Angoulvant, Adela; Bendib, Ines; Gagnard, Jean- Charles; Bourhis, Jean-Henri; Darg |
Report |
Jun 1, 2017 |
1522 |
| Stem cell repair of blood-spinal cord barrier: Hope for ALS treatment. |
|
|
May 29, 2017 |
478 |
| Self-renewing hematopoietic stem cells created for transplantation. |
|
|
May 29, 2017 |
561 |
| Stem cell repair of blood-spinal cord barrier: Hope for ALS treatment. |
|
|
May 29, 2017 |
478 |
| Self-renewing hematopoietic stem cells created for transplantation. |
|
|
May 29, 2017 |
558 |
| Stem cell repair of blood-spinal cord barrier: hope for ALS treatment. |
Garbuzova-Davis, Svitlana |
|
May 22, 2017 |
477 |
| Self-renewing hematopoietic stem cells created for transplantation. |
Rafii, Shahin |
|
May 22, 2017 |
556 |
| Graft-Versus-Host disease prevented after stem cell transplants. |
|
|
Apr 24, 2017 |
443 |
| Diplomat reports distribution of REVLIMID for multiple myeloma maintenance therapy. |
|
|
Mar 3, 2017 |
137 |
| Diplomat reports distribution of REVLIMID for multiple myeloma maintenance therapy. |
|
|
Mar 3, 2017 |
133 |
| Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting. |
Kaya, Ali Hakan; Tekgunduz, Emre; Duygu, Fazilet; Koca, Dicle; Bekdemir, Filiz; Batgi, Hikmetullah; |
Report |
Mar 1, 2017 |
4445 |
| Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience. |
Fasano, Ross M.; Sullivan, Harold Cliff; Bray, Robert A.; Gebel, Howard M.; Meyer, Erin K.; Winkler, |
Report |
Mar 1, 2017 |
11255 |
| Rhodococcus infection in solid organ and hematopoietic stem cell transplant recipients. |
Vergidis, Pascalis; Ariza-Heredia, Ella J.; Nellore, Anoma; Kotton, Camille N.; Kaul, Daniel R.; Mor |
|
Mar 1, 2017 |
2464 |
| US Merck Touts Study Data on Letermovir Investigational Antiviral Medicine. |
|
|
Feb 28, 2017 |
562 |
| FDA Expands Indication for Celgene's Rrevlimid as a Maintenance Treatment for Patients with Multiple Myeloma. |
|
|
Feb 24, 2017 |
301 |
| Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia. |
Wang, Lu; Liu, Dai-Hong |
|
Feb 1, 2017 |
2610 |
| Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation. |
Resende, C.B.; Rezende, B.M.; Bernardes, P.T.T.; Teixeira, G.M.; Teixeira, M.M.; Pinho, V.; Bittenco |
Report |
Feb 1, 2017 |
4037 |
| BK Virus Encephalitis in HIV-infected Patients: Case Report and Review. |
Antoniolli, Luciana; Borges, Rafael; Goldani, Luciano Z. |
Report |
Jan 1, 2017 |
3021 |
| Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia. |
Bras, G.; Pinho-Vaz, C.; Campos, A. |
Case study |
Jan 1, 2017 |
2982 |
| Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment. |
Hsu, Brend Ray-Sea; Fu, Shin-Huei; Wang, Aline Yen Ling |
Report |
Jan 1, 2017 |
6188 |
| Evaluation of Quality of Life and Care Needs of Turkish Patients Undergoing Hematopoietic Stem Cell Transplantation. |
Yasar, Neslisah; Akin, Semiha |
|
Jan 1, 2017 |
8176 |
| Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia. |
Anders, Brandi; Veltri, Lauren; Kanate, Abraham S.; Shillingburg, Alexandra; Shah, Nilay; Craig, Mic |
|
Jan 1, 2017 |
2334 |
| Utility of Endoscopic Examination in the Diagnosis of Acute Graft-versus-Host Disease in the Lower Gastrointestinal Tract. |
Nomura, Kosuke; Iizuka, Toshiro; Kaji, Daisuke; Yamamoto, Hisashi; Kuribayashi, Yasutaka; Tanaka, Ma |
Report |
Jan 1, 2017 |
3560 |
| Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation. |
Zhao, Xiaosu; Zhao, Xiangyu; Huo, Mingrui; Fan, Qiaozhen; Pei, Xuying; Wang, Yu; Zhang, Xiaohui; Xu, |
Report |
Jan 1, 2017 |
4988 |
| Necrotizing Liver Granuloma/Abscess and Constrictive Aspergillosis Pericarditis with Central Nervous System Involvement: Different Remarkable Phenotypes in Different Chronic Granulomatous Disease Genotypes. |
Akarcan, Sanem Eren; Karaca, Neslihan; Aksu, Guzide; Bozkaya, Halil; Ayik, Mehmet Fatih; Sahan, Yase |
Clinical report |
Jan 1, 2017 |
4686 |
| Gain-of-Function Mutations in STAT1: A Recently Defined Cause for Chronic Mucocutaneous Candidiasis Disease Mimicking Combined Immunodeficiencies. |
Akarcan, Sanem Eren; Severcan, Ezgi Ulusoy; Karaca, Neslihan Edeer; Isik, Esra; Aksu, Guzide; Migaud |
Clinical report |
Jan 1, 2017 |
3393 |
| Antinociceptive Effect of Intrathecal Injection of Genetically Engineered Human Bone Marrow Stem Cells Expressing the Human Proenkephalin Gene in a Rat Model of Bone Cancer Pain. |
Sun, Yi; Tian, Yuke; Li, Haifeng; Zhang, Dengwen; Sun, Qiang |
Report |
Jan 1, 2017 |
6439 |
| Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation. |
Fan, Liping; Fu, Danhui; Zhang, Jinping; Huang, Haobo; Wang, Qingqing; Ye, Yamei; Xie, Qianling |
Report |
Jan 1, 2017 |
4584 |
| Hematopoietic Stem Cell Transplantation: A Bioethical Lens. |
Liso, Arcangelo; Neri, Margherita; Maglietta, Francesca; La Russa, Raffaele; Turillazzi, Emanuela |
Report |
Jan 1, 2017 |
9672 |
| Lymphocytes in Placental Tissues: Immune Regulation and Translational Possibilities for Immunotherapy. |
Erkers, Tom; Stikvoort, Arwen; Uhlin, Michael |
Report |
Jan 1, 2017 |
15471 |
| Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia. |
Wang, Mengning; Yang, Chuanwei; Zhang, Le; Schaar, Dale G. |
Report |
Jan 1, 2017 |
8367 |
| High-Risk Neuroblastoma with Metastases to Bilateral Kidneys at Diagnosis. |
Yoshikawa, Toshihide; Tanizawa, Akihiko; Suzuki, Koji; Ikeda, Kazumi; Nomura, Eishi; Maeda, Yumekich |
Clinical report |
Jan 1, 2017 |
2197 |
| Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML. |
Fakhri, Bita; Fiala, Mark; Slade, Michael; Westervelt, Peter; Ghobadi, Armin |
Clinical report |
Jan 1, 2017 |
1965 |
| A Case of Elastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry. |
Pennisi, Martina; Cesana, Clara; Cittone, Micol Giulia; Bandiera, Laura; Scarpati, Barbara; Mancini, |
Clinical report |
Jan 1, 2017 |
3019 |
| Posttransplant Lymphoproliferative Disorder in a Patient with Worsening Ascites after Liver Transplantation. |
Patel, Harsh D.; Rubin, Moises I. Nevah |
Clinical report |
Jan 1, 2017 |
1936 |
| A Child as a Donor for Hematopoietic Stem Cell Transplantation: Bioethical Justification--A Case Study on Sickle Cell Disease. |
Pereira, Andrea Z.; Hellman, Ricardo; Hamerschlak, Nelson; Kondo, Andrea; de Souza, Polianna Mara Ro |
Clinical report |
Jan 1, 2017 |
3789 |
| A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations. |
Atilla, Erden; Atilla, Pinar Ataca; Demirer, Taner |
Report |
Jan 1, 2017 |
7236 |
| HSCT beats cyclophosphamide for systemic disease in trial. |
Worcester, Sharon |
|
Jan 1, 2017 |
573 |
| MicroRNA modulation during the in vitro culture of hematopoietic stem cells prior to transplantation. |
Shahrabi, Saeid; Kaviani, Saeid; Soleimani, Masoud; Pourfathollah, Ali Akbar; Bakhshandeh, Behnaz; H |
Report |
Jan 1, 2017 |
4783 |
| Possible Mechanism of Therapeutic Effect of 3-Methyl-1-phenyl-2-pyrazolin-5-one and Bone Marrow Stromal Cells Combination Treatment in Rat Ischemic Stroke Model. |
Shen, Li-Hua; Chen, Jin; Shen, Hua-Chao; Ye, Min; Liu, Xiao-Fei; Ding, Wen-Sen; Sheng, Ya-Feng; Ding |
Report |
Dec 1, 2016 |
4113 |
| United States : New results presented for Opdivo (nivolumab) demonstrate encouraging response rate in an expanded population of heavily pre-treated classical Hodgkin Lymphoma patients. |
|
|
Oct 26, 2016 |
551 |
| Merck meets primary endpoint in phase three clinical trial of letermovir. |
|
|
Oct 21, 2016 |
168 |
| Merck meets primary endpoint in phase three clinical trial of letermovir. |
|
|
Oct 21, 2016 |
164 |
| Canada,United States : Merck Announces Pivotal Phase 3 Study of Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) Infection in High-Risk Bone Marrow Transplant Patients, Met Primary Endpoint. |
|
Clinical report |
Oct 20, 2016 |
226 |
| Actinium Pharmaceuticals wins EMA orphan designation for radioimmunoconjugate Iomab-B. |
|
|
Oct 19, 2016 |
262 |
| Actinium Pharmaceuticals wins EMA orphan designation for radioimmunoconjugate Iomab-B. |
|
|
Oct 19, 2016 |
258 |
| SCIDNET: DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID). |
|
|
Oct 13, 2016 |
528 |
| TREGeneration: Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes. |
|
|
Oct 8, 2016 |
508 |
| Peripheral blood CD34+ cell count as a predictor of adequacy of hematopoietic stem cell collection for autologous transplantation/Recuento de celulas CD34+ en sangre periferica como predictor de adecuada recoleccion de progenitores hematopoyeticos para trasplante autologo/Contagem de celulas CD34+ em sangue periferico como preditor de adequada recoleccao de progenitores hematopoieticos para transplante autologo. |
Combariza, Juan F.; Barco, Gloria; Estrada, Angela; Jaramillo, Sergio; Arango, Marcos |
|
Oct 1, 2016 |
3761 |
| Infection-related death among persons with refractory juvenile idiopathic arthritis. |
Abinun, Mario; Lane, Jonathan P.; Wood, Mark; Friswell, Mark; Flood, Terence J.; Foster, Helen E. |
|
Oct 1, 2016 |
7167 |
| United States : Amgen announces Top-Line Results From Phase 3 KYPROLIS (Carfilzomib) CLARION Study In Newly Diagnosed Multiple Myeloma Patients. |
|
Clinical report |
Sep 28, 2016 |
486 |
| Supply Of A Similar Flow Cytometry Diagnostic Service (luminex Technology) For Hla Typing And Analysis Of Sera For Purposes Compatibility Study For Org. |
|
|
Aug 31, 2016 |
167 |
| Decreased vitamin C levels found in patients treated for hematologic malignancies. |
|
Brief article |
Aug 1, 2016 |
227 |
| New Market Research Report: Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2016. |
|
|
Jun 2, 2016 |
477 |
| Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report. |
Cai, H.; Shen, H. |
Case study |
Jun 1, 2016 |
2293 |
| Treating myasthenia gravis with stem cell transplants. |
|
|
Apr 18, 2016 |
225 |
| Pluristem granted two cell therapy patents in Japan. |
|
|
Apr 18, 2016 |
185 |
| Treating myasthenia gravis with stem cell transplants. |
|
|
Apr 18, 2016 |
225 |
| Pluristem granted two cell therapy patents in Japan. |
|
|
Apr 18, 2016 |
147 |
| Treating myasthenia gravis with stem cell transplants. |
|
|
Apr 11, 2016 |
226 |
| Positive early results from pilot study of blood cytokine in stem cell harvest. |
|
|
Mar 14, 2016 |
311 |
| Preliminary data from pilot study of blood cytokine in stem cell harvest. |
|
|
Mar 7, 2016 |
310 |
| Preliminary data from pilot study of blood cytokine in stem cell harvest. |
|
|
Mar 7, 2016 |
310 |
| Newly identified genes needed for transplantation of blood-forming stem cells. |
|
|
Feb 29, 2016 |
425 |
| "Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015" Published. |
|
|
Feb 4, 2016 |
478 |
| HLA typing: conventional techniques v. next-generation sequencing. |
Mellet, J.; Gray, C.M.; Pepper, M.S. |
Report |
Jan 1, 2016 |
3800 |
| DAS181 treatment of severe parainfluenza virus 3 pneumonia in allogeneic hematopoietic stem cell transplant recipients requiring mechanical ventilation. |
Dhakal, B.; D'Souza, A.; Pasquini, M.; Saber, W.; Fenske, T.S.; Moss, R.B.; Drobyski, W.R.; Hari, P. |
Case study |
Jan 1, 2016 |
2683 |
| Acute kidney injury in hematopoietic stem cell transplantation: a review. |
Krishnappa, Vinod; Gupta, Mohit; Manu, Gurusidda; Kwatra, Shivani; Owusu, Osei-Tutu; Raina, Rupesh |
Clinical report |
Jan 1, 2016 |
10206 |
| High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana. |
Hauser, Naomi; Sahai, Tanmay; Richards, Rocco; Roberts, Todd |
Case study |
Jan 1, 2016 |
1752 |
| Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia. |
|
|
Dec 31, 2015 |
2838 |
| Laboratory testing services of telomere length assays for validation study of the role of donor and recipient telomere length in outcomes after hematopoietic stem cell transplant in patients with acqu. |
|
|
Dec 2, 2015 |
116 |
| Celgene International SA rl awarded EC approval for VIDAZA for treating adult patients with AML who are not eligible for haematopoietic stem cell transplantation. |
|
|
Nov 2, 2015 |
276 |
